Camostat Completed Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04524663Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients
NCT04583592Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)